0.00Open3.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover3542.27%IV3.85%PremiumJul 19, 2024Expiry Date2.82Intrinsic Value100Multiplier-4DDays to Expiry0.18Extrinsic Value100Contract SizeAmericanOptions Type-0.8841Delta0.1199Gamma1.56Leverage Ratio-4.3132Theta0.0000Rho-1.38Eff Leverage0.0001Vega
TELA Bio Stock Discussion
NEWS
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
TELA Bio, Inc. announces the U.S. commercial launch of OviTex IHR, a reinforced tissue matrix for inguinal hernia repair. The product offers trocar-compatibility for laparoscopic and robotic procedures, with three configurations available. OviTex has a strong clinical track record with low recurrence rates and high pati...
Beat revenue estimates and near miss on GAAP.
FDA approved surgical device
Buy this asap
No comment yet